Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David M. Wellsted
Rationale and Design of “Can Very Low Dose Rivaroxaban (VLDR) in Addition to Dual Antiplatelet Therapy Improve Thrombotic Status in Acute Coronary Syndrome (VaLiDate-R)” Study
Journal of Thrombosis and Thrombolysis
Cardiovascular Medicine
Hematology
Cardiology
Related publications
The Underutilisation of Dual Antiplatelet Therapy in Acute Coronary Syndrome
International Journal of Cardiology
Cardiovascular Medicine
Cardiology
Antiplatelet Therapy in Acute Coronary Syndrome
Continuing Cardiology Education
The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
Annals of Internal Medicine
Internal Medicine
Medicine
Factors Associated With Platelet Reactivity During Dual Antiplatelet Therapy in Patients With Diabetes After Acute Coronary Syndrome
Scientific Reports
Multidisciplinary
Old and New Players in Oral Antiplatelet Therapy in Treatment of Acute Coronary Syndrome
Nepal Journal of Medical Sciences
Rivaroxaban in Patients With a Recent Acute Coronary Syndrome
Indian Heart Journal
Cardiovascular Medicine
Cardiology
Rationale and Role of High Loading Dose Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Pharmacology & Pharmacy
Is There a Rationale for Antiplatelet Therapy in Acute Heart Failure?
Circulation. Heart failure
Medicine
Cardiovascular Medicine
Cardiology
